
Biologic Overlap During Medication Switches Is Safe in IBD
TOPLINE: Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping biologic therapy, indicating that shorter washout …